Back to search
FDAFDA · Food and drugs·Recall number Z-0426-2021

EDI Novel Coronavirus COVID-19 IgG ELISA Kit, REF: KT-1032 Per label: This kit is intended for qualitative detection of human anti-COVID-19 IgG antibody in human serum. This kit is to be used as an aid for the detection of novel COVID-19. Patients with suspected clustering cases require diagnosis or differential diagnosis of novel coronavirus infection.

Published November 18, 2020 · Recall initiated: October 1, 2020

Summary

FDA records medical device Class II recall Z-0426-2021, published November 18, 2020 and initiated October 1, 2020. Recalling firm: Epitope Diagnostics, Inc.; Status: Ongoing; Reported quantity: 2886; Lot: Lot Numbers: P826, P815, P796, P776. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The use of deionized water rather than distilled water during the manufacturing process, may have resulted in accelerated decreased OD signals for the Positive Control value.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Epitope Diagnostics, Inc.
Distributor
U.S Distribution.: NH, CO, OR, CA, FL, NY, MD, NJ, IL, NC, MI, TX, PA, MA, OH, NM, VA, SC, HI, and TN.
Lot
Lot Numbers: P826, P815, P796, P776
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was EDI Novel Coronavirus COVID-19 IgG ELISA Kit, REF: KT-1032 Per label: This kit is intended for qualitative detection of human anti-COVID-19 IgG antibody in human serum. This kit is to be used as an aid for the detection of novel COVID-19. Patients with suspected clustering cases require diagnosis or differential diagnosis of novel coronavirus infection. recalled?

Yes. FDA published recall Z-0426-2021 on November 18, 2020. Reported hazard: The use of deionized water rather than distilled water during the manufacturing process, may have resulted in accelerated decreased OD signals for the Positive Control value.

What should I do if I have this product?

Voluntary: Firm initiated · Letter